Within-subject variability of measures of beta cell function derived from a 2 h OGTT: Implications for research studies

Diabetologia

Volumn 50, Issue 12, 2007, Pages 2516-2525

  Utzschneider, K M ^a,b   Prigeon, R L ^c,d   Tong, J ^a,b   Gerchman, F ^a,b   Carr, D B ^b   Zraika, S ^a,b   Udayasankar, J ^a,b   Montgomery, B ^a,b   Mari, A ^e   Kahn, S E ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e CNR   (Italy)

Author keywords

Beta cell function; Insulin secretion; Insulin sensitivity; Insulinogenic index; Reproducibility

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MATHEMATICAL MODEL; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; MODELS, THEORETICAL; OBSERVER VARIATION; PANCREATIC FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 35848938702     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0819-5     Document Type: Article

References (19)

1. Mooy JM, Grootenhuis PA, de Vries H et al (1996) Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39:298-305
2. Yudkin JS, Alberti KG, McLarty DG, Swai AB (1990) Impaired glucose tolerance. BMJ 301:397-402
3. Harding PE, Oakley NW, Wynn V (1973) Reproducibility of oral glucose tolerance data in normal and mildly diabetic subjects. Clin Endocrinol (Oxf) 2:387-395
4. Wolever TM, Chiasson JL, Csima A et al (1998) Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal vs 75 g oral glucose. Diabetes Care 21:336-340
5. Morgan C, Lazarow A (1963) Immunoassay of insulin: two antibody systems. Diabetes 12:115-126
6. Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
7. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159-E1166
8. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191-2192
9. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548
10. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
11. Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295-301
12. van Belle G, Martin DC (1993) Sample size as a function of coefficient of variation and ratio of means. Am Stat 47:165-167
13. Efron B, Tibshirani R (1993) An introduction to the bootstrap. Chapman & Hall/CRC, Boca Raton
14. Abbate SL, Fujimoto WY, Brunzell JD, Kahn SE (1993) Effect of heparin on insulin-glucose interactions measured by the minimal model technique: Implications for reproducibility using this method. Metabolism 42:353-357
15. Schousboe K, Henriksen JE, Kyvik KO, Sorensen TI, Hyltoft Petersen P (2002) Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests. Scand J Clin Lab Invest 62:623-630
16. Mari A, Nielsen LL, Nanayakkara N, Defronzo RA, Ferrannini E, Halseth A (2006) Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea. Horm Metab Res 38:838-844
17. Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E (2005) Beta-cell function in mild type 2 diabetic patients: Effects of 6-month glucose lowering with nateglinide. Diabetes Care 28:1132-1138
18. Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672
19. Valdes CT, Elkind-Hirsch KE (1991) Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab 72:642-646